Telehealth

Upliv is expected to receive $8.4 million in seed funding through the end of 2023.

An analysis performed by Chartis and Kythera Labs also shows those between ages 18 to 44 have highest telehealth usage.

The company is seeking new partnerships to expand its virtual home care programme.

The Digital Innovation Showcase saw five startups pitching their solutions to a panel of judges and healthcare industry professionals from the APAC region. 

The analysis found mean daily requests for abortion medications provided through Aid Access were 82.6 during the baseline period. They reached 213.7 after the Supreme Court decision overturning Roe v. Wade was announced.

The pre-seed will be used to expand the startup's clinical operations and research as well as improve its proprietary clinical protocols.

The health systems say the virtual and in-home care company, called Ovatient, will provide more convenient offerings and a connection to higher-level care when needed.

According to a study published in JAMA Network Open, telehealth follow-up was associated with 28.3 more repeat ED visits per 1,000 patients compared with in-person care.

The virtual care giant reported revenue of $611.4 million, a 17% year-over-year increase, and a net loss of $73.5 million in the third quarter.

Partner hospitals will be provided with telemedicine support and resources to mobilise critical stroke patients.